Five potential first-in-class assets aimed at delivering significant long-term growth. Over 14 clinical development programs underway across portfolio and 11 new studies to start in 2022 across early- and late-stage pipeline
The industry is at an inflection point and it awaits mega investments, the right government policies, and the creation of a strong ecosystem to propel innovation
The interim data combines three mRNAs into one therapy injected directly into the tumour
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
Aster DM Healthcare announced its financial results for the quarter ended September 30, 2021
The centre has an initial capacity of 500 FTEs
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
The company has operations in North America, Asia, and Europe,
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
Subscribe To Our Newsletter & Stay Updated
